1.98 USD
↘ 0.11 (5.26%)AT CLOSE (03:59 PM EDT)
Seres Therapeutics, Inc.
MCRBNASDAQ • USD
1.99
↗ 0.01 (0.51%)
POST MARKET (AS OF 07:38 PM EDT)
Post Market
AS OF 07:38 PM EDT
1.99
↗ 0.01 (0.51%)
Market: CLOSED
Seres Therapeutics, Inc. (MCRB) trades at $2.02 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place MCRB at a fair price relative to peers.
Technical & fundamental data as of Oct 26, 2026.
Open?$2.11
High?$2.19
Low?$1.98
Prev. Close?$2.09
Volume?53.1K
Avg. Volume?71.8K
VWAP?$2.04
Rel. Volume?0.74x
Bid / Ask
Bid?$1.98 × 500
Ask?$2.00 × 100
Spread?$0.02
Midpoint?$1.99
Valuation & Ratios
Market Cap?19.9M
Shares Out?10.0M
Float?7.1M
Float %?71.0%
P/E Ratio?N/A
P/B Ratio?0.58
EPS?-$2.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Employees
66
Market Cap
21.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-06-26
Address
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617 945 9626
CAMBRIDGE, MA 02139
Phone: 617 945 9626
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?62
Short Sent.?49
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.88Distress
Confidence?50%Low
Short InterestModerate
Short % of Float?4.43%Low
Short Interest?312.3K
Days to Cover?3.5
Free Float7.1M
Avg Daily Volume90.6K
Settlement Date2026-10-15
Financial Health
Current Ratio?2.11Strong
Quick Ratio?2.11Strong
Cash Ratio?0.78Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?0.58CHEAP▾
Peers100
S&P97
P/S?10.56HIGH▾
Peers100
S&P7
P/FCF?N/A▾
EV/EBITDA?-0.1CHEAP▾
S&P97
EV/Sales?2.28CHEAP▾
Peers100
S&P71
Returns & Efficiency
ROE?-65.1%WEAK▾
S&P3
ROA?-22.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-51295000
Enterprise Value?$4.3M
Fundamentals ratios updated end of day